CTVQ enters US Outpatient Market via SimonMed 170 sites
Open PDF
| Stock | 4DMEDICAL Ltd (4DX.ASX) |
|---|---|
| Release Time | 29 May 2026, 10:03 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
4DMedical Secures Major Contract with SimonMed in the US
Key Points
- 4DMedical signs commercial contract with SimonMed Imaging
- Agreement involves deployment of CT:VQ and LDAf solutions
- SimonMed operates over 170 outpatient imaging centers across 10 states
- Partnership aims to develop reimbursement evidence for CT:VQ
- Agreement reflects confidence in 4DMedical's technology
Full Summary
4DMedical Limited, a global leader in respiratory imaging technology, has entered into a commercial agreement with SimonMed Imaging, a leading outpatient medical imaging provider in the United States. This agreement involves the deployment of 4DMedical's advanced quantitative cardiopulmonary analysis solutions, CT:VQ and LDAf, across SimonMed's network of over 170 imaging centers in 10 states. The partnership aims to support enhanced clinical decision-making for pulmonary assessment, leveraging 4DMedical's scalable SaaS delivery model. The three-year agreement, with pricing based on per-scan rates, reflects growing confidence in the technology and represents a significant commercial opportunity for 4DMedical.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In